Finding the right path for ADHD care
As ADHD medicine use surges and prescribing pathways evolve, pharmacists are increasingly acting as a clinical safety net and health system navigator.
Do you feel confident managing medicines in dementia care?
Many pharmacists feel underprepared for navigating medicines management in people with dementia. AP explores where the knowledge gaps lie and how to close them during Dementia Action Week 2026 (21–27 September).
When normal glucose doesn’t mean normal risk
A patient can develop diabetic ketoacidosis even when their glucose reading looks normal. Here’s why pharmacists need to keep an eye on ketones, particularly in people taking SGLT2 inhibitors.
Where can pharmacists get funding for prescribing training?
Pharmacists across Australia can access thousands in government funding to complete PSA’s Graduate Certificate in Pharmacist Prescribing.
Why harm reduction services should be a part of every pharmacy
One month into her term as PSA’s inaugural Harm Reduction Champion, Krishna Nathwani MPS sat down with AP to discuss the importance of patient education, why holistic care matters and the barriers patients encounter when seeking services.
POPULAR
Finding the right path for ADHD care
As ADHD medicine use surges and prescribing pathways evolve, pharmacists are increasingly acting as a clinical safety net and health system navigator.
Do you feel confident managing medicines in dementia care?
Many pharmacists feel underprepared for navigating medicines management in people with dementia. AP explores where the knowledge gaps lie and how to close them during Dementia Action Week 2026 (21–27 September).
When normal glucose doesn’t mean normal risk
A patient can develop diabetic ketoacidosis even when their glucose reading looks normal. Here’s why pharmacists need to keep an eye on ketones, particularly in people taking SGLT2 inhibitors.
Where can pharmacists get funding for prescribing training?
Pharmacists across Australia can access thousands in government funding to complete PSA’s Graduate Certificate in Pharmacist Prescribing.
Why harm reduction services should be a part of every pharmacy
One month into her term as PSA’s inaugural Harm Reduction Champion, Krishna Nathwani MPS sat down with AP to discuss the importance of patient education, why holistic care matters and the barriers patients encounter when seeking services.
POPULAR
A cup of tea, a Bex and a good lie down
Immortalised in Australian slang, the analgesic phenacetin (used in Bex powder) is wrapped up in the development of the modern pharmaceutical industry and has...
Pfizer COVID-19 vaccine health hubs announced
The Federal Government is calling on community pharmacists to help vaccinate millions of Australians against COVID-19.
Landmark Australian study on oxycodone prescribing
Oxycodone is the most prescribed strong opioid in Australia. Yet little was known about its use and prescribing patterns – until now.
Triptans downscheduled to S3 medicines
Last year, the Therapeutic Goods Administration announced that certain triptans will be available over the counter in 2021.
New CAL D instruction for antibiotics
A new cautionary advisory label for antibiotics that will replace decades of advice to take the medicines ‘until all used’ or ‘until all taken’ will be released next year.
What impact will Wegovy have on the obesity epidemic?
The latest injectable glucagon-like peptide-1 receptor agonist, Wegovy, became available in Australia last week (5 August 2024).
